GW & Wade’s Veracyte VCYT Stock Holding History

GW & Wade’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-10,750	Closed	-$78K	–	244
2015 Q1	$78K	Buy	+10,750	New	+$88.1K	0.01%	236

Other funds holding VCYT

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Clough Capital Partners Boston, Massachusetts $1.04B AUM 49.7% 1-Year Est. Return

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

GW & Wade's VCYT Position: Q2 2015 in Review

GW & Wade sold out of Veracyte (VCYT) in Q2 2015, closing a stake of 10,750 shares — an estimated $78K sold.

GW & Wade first reported a position in VCYT in Q1 2015 and held it in 1 quarter. The position peaked at $78K in Q1 2015. 60 funds tracked by Wall St. Rank hold VCYT as of Q2 2015.

GW & Wade reported no remaining Veracyte position as of Q2 2015 after selling out during the quarter.
GW & Wade sold 10,750 Veracyte shares in Q2 2015, an estimated $78K.
GW & Wade first reported a position in Veracyte in Q1 2015 and held it in 1 quarter.
GW & Wade's Veracyte position peaked at $78K in Q1 2015.
60 funds tracked by Wall St. Rank held Veracyte as of Q2 2015.

Based on GW & Wade's 13F filing for Q2 2015, filed 14 Aug 2015.